Close Menu

chromosomal abnormalities

Three new studies, published online in the New England Journal of Medicine, shed light on how NIPT may be best integrated into clinical care for all pregnant women.

The Swiss firm is paying $260,000 for InKaryo and will assume its $280,000 convertible bond debt obligation.

NEW YORK (GenomeWeb News) – Sequenom and CombiMatrix today announced an agreement to market chromosomal microarray analysis testing services "to broaden and confirm the results of non-invasive prenatal testing" to doctors and patients.

NEW YORK (GenomeWeb News) – Looking to enter the fast-growing non-invasive prenatal diagnostics space, CellScape is eyeing a second-half 2014 commercial launch of its test, which detects for fetal aneuploidies, and more importantly, genetic disorders that currently require invasive methods for de

Illumina and Kindstar Global announced last week that they have made an agreement that allows Kindstar to offer a set of Illumina products, including the Infinium Dx CytoSNP-12 BeadChip assay, to its Chinese clients.

Life Technologies will sell the kits for chromosomal abnormalities under the Applied Biosystems name. The agreement, however, does not include the US.

The settlement, which will be funded by insurance proceeds, relates to a lawsuit filed in November by Sequenom's shareholders alleging mishandling of data surrounding the company's SEQureDx test.

Pages

23andMe and Airbnb have partnered to offer "heritage travel," according to Venture Beat.

China may include regulations protecting genes and embryos in its update of its civil code, Nature News reports.

In Nature this week: exome sequence analysis of individuals with type 2 diabetes, genomic prediction of maize yield across environments, and more.

NPR reports on efforts to engineer bacteriophages to destroy antibiotic-resistance bacteria.